上海市第十人民医院心内科行政副主任，心血管急危重学科带头人，心衰中心主任。中华预防医学会循证医学专业委员会副主任委员，中华医学会心血管病学分会动脉粥样硬化与冠心病学组委员，中华中医药学会络病分会常务委员，中国医师协会心力衰竭学会委员，中国康复医学会心血管病专业学会委员，中国老年学会心脑血管病专业分会委员，美国心脏病学院（ACC）委员(FACC)，美国心脏病学会(AHA)专业委员，中国心衰联盟执行委员，Journal of Clinical Trial主编, 中国循证心脏病学杂志常务编委，临床心血管病杂志编委。
Department of Cardiology, Shanghai Tenth People's Hospital; Chief of Cardiovascular Emergency and Critical Care; Director of Heart Failure Center. Deputy Chairman of the Evidence-Based Medicine Committee of the Chinese Preventive Medicine Association, Member of the Atherosclerosis and Coronary Heart Disease Group of the Cardiovascular Disease Branch of the Chinese Medical Association, Standing Member of the Luo Disease Branch of the Chinese Association of Traditional Chinese Medicine, Member of the Heart Failure Society of the Chinese Medical Doctor Association, Member of the Cardiovascular Disease Professional Society of the Chinese Rehabilitation Medicine Association, Member of the Cardiovascular and Cerebrovascular Diseases Professional Branch of the Chinese Geriatric Society, Fellow (FACC) of the American College of Cardiology (ACC), Professional Member of the American Heart Association (AHA), Executive Committee Member of the Chinese Heart Failure Alliance, Editor-in-Chief of Journal of Clinical Trial, Deputy Chief Editor of the Chinese Journal of Evidence-Based Cardiology, Editorial Board Member of Clinical Cardiovascular Diseases Journal.
已在国际和国内发表论文120余篇，其中SCI论文90余篇，主编和参编中英文著作8部，其中主编《临床心电图学及图谱》、《冠心病的现代治疗》、独著《心力衰竭的现代管理》。参与编写中国心血管疾病多项诊疗指南。主持国家和上海自然科学基金等国家和省部级课题十余项，曾获中国中医药促进会科技进步一等奖，上海市科学技术奖三等奖和医学科技奖三等奖两项，河南科学技术奖三等奖和医学科技奖一等奖各一项。
Our team has published over 120 academic papers both internationally and domestically, among which more than 90 are indexed in SCI. I have served as chief editor or contributing editor for 8 academic works in Chinese and English. Specifically, I am the chief editor of Clinical Electrocardiography and Atlas and Modern Treatment of Coronary Heart Disease, and the sole author of Modern Management of Heart Failure. I have participated in the compilation of multiple national clinical practice guidelines for cardiovascular diseases in China. I have presided over more than 10 national and provincial-level research projects, including those funded by the National Natural Science Foundation of China and the Shanghai Natural Science Foundation. I have also been honored with several academic awards: the First Prize of Science and Technology Progress Award from the China Association for the Promotion of Traditional Chinese Medicine, one Third Prize of Shanghai Science and Technology Award, two Third Prizes of Shanghai Medical Science and Technology Award, one Third Prize of Henan Science and Technology Award, and one First Prize of Henan Medical Science and Technology Award.
【近三年发表论文（通讯作者）】
1. Development and external validation of a prognostic model for new-onset atrial fibrillation complicating acute myocardial infarction: insights from the NOAFCAMI-China registry. Eur Heart J. Acute Cardiovasc Care. 2025 Sep 17:doi: 10.1093
2. The Role of MCPIP1 in Macrophage Polarization and Cardiac Function Post-Myocardial Infarction. Adv Sci (Weinh). 2025 Jul;12(25):e2500747.
3. Association of Atrial Fibrillation Burden With Cardiovascular Outcomes in New-Onset Atrial Fibrillation Complicating Myocardial Infarction. NOAFCAMI‐China Registry Investigators. J Am Heart Assoc. 2025 May 20;14(10):e039547.
4. Influence of Left Ventricular Mass Index on Clinical Outcomes in Patients with Acute Myocardial Infarction. Int Heart J. 2025 Mar 31;66(2):193-201.
5. Prognostic impact of new-onset atrial fibrillation in myocardial infarction with and without improved ejection fraction. NOAFCAMI‐SH Registry Investigators. ESC Heart Fail. 2024 Dec;11(6):3713-3722.
6. Association of stress hyperglycemia ratio with in-hospital new-onset atrial fibrillation and long-term outcomes in patients with acute myocardial infarction. Diabetes Metab Res Rev. 2024 Feb;40(2):e3726.
7. Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry. Cardiovasc Diabetol. 2024 Jan 22;23(1):41.
8. TRIM21 deficiency protects against atrial inflammation and remodeling post myocardial infarction by attenuating oxidative stress. Redox Biol. 2023 Jun;62:102679
9. Prognostic implications of the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction. Eur J Intern Med. 2023 Apr 8:S0953-6205.
